CARDIOGENESIS REPORTS 2005 FOURTH QUARTER, YEAR-END RESULTS

Cardiogenesis Corporation, the market leader in surgical products and accessories used in angina-relieving Transmyocardial Revascularization (TMR) and Percutaneous Myocardial Channeling procedures, announced results today for its fourth quarter and year ended December 31, 2005.
MSN Money